PARP inhibitors in breast and ovarian cancer with BRCA mutations: a meta-analysis of survival

Objective: To evaluate the efficacy of poly ADP ribose polymerase (PARP) inhibitors (PARPis) in breast and ovarian cancer with BRCA (BReast CAncer susceptibility gene) mutation (BRCAm). Methods: We conducted a meta-analysis of randomized controlled, phase II or III trials by searching of electronic...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, Fengping, Duan, Yaoyun, Zhao, Yunhe, Li, Yinguang, Liu, Jun, Zhang, Cai, He, Shanyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034970/
https://www.ncbi.nlm.nih.gov/pubmed/33705352
http://dx.doi.org/10.18632/aging.202724

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034970/
https://www.ncbi.nlm.nih.gov/pubmed/33705352
http://dx.doi.org/10.18632/aging.202724

Ejemplares similares